期刊文献+

咖啡因对6-羟基多巴胺诱导大鼠帕金森病模型作用的量效关系 被引量:2

Investigation on the Dose-effect Relationship of Caffeine to PD Model Rats Induced by 6-OHDA
在线阅读 下载PDF
导出
摘要 目的:探讨咖啡因对大鼠6-羟基多巴胺(6-OHDA)诱导的帕金森模型作用的量效关系及其最佳用量。方法:应用6-OHDA制备成年大鼠右侧损毁的帕金森病模型,通过外周注射阿朴吗啡促使大鼠旋转次数作为对其病情进行定量检测的指标。用已知不同剂量的咖啡因每天对大鼠灌胃进行治疗,以大鼠旋转次数为主要指标,判断其对帕金森病治疗效果的变迁情况,以探讨咖啡因治疗帕金森病的最佳剂量。结果:咖啡因(30,40,50mg/kg BW)有明显治疗效果,但咖啡因40,50mg/kg BW组对大鼠有可能产生生存质量影响。结论:30mg/kg BW是咖啡因治疗6-OHDA制备帕金森大鼠模型的有效剂量,咖啡因对帕金森病的疗效随剂量增长,到一定剂量时则不再增长。 Objective:To investigate the best dose of caffeine and the dose-effect relationship of caffeine to PD model rats by 6-OHDA. Methods:Rat model with Parkinson disease was built up by direct injecting 6- OHDA into sub stantia nigra pars compacta(SNc)with stereotactic technique. Apomorphine(0. 25mg/kg)was injected celiac to evocate circle behavior. Changes of caffeine effect to PD models were observed by admistrating different doses of caffeine taking the frequency of circle behavior as main index. Results: There were obvious effect on caffeine(30,40,50mg/kg BW)group, but for the rats in caffeine(40,50mg/kg BW), there would be some influencing factors for their living. Conclusion:30mL/kg rat weight was the best caffeine dose on PD model rats by 6-OHDA. The effect was positive correlation to the dose of caffeine, wouldn't grow when the dose came to a fixed amount.
出处 《河北北方学院学报(医学版)》 2010年第1期36-38,共3页 Journal of Hebei North University:Medical Edition
关键词 咖啡因 帕金森病 量效关系 6-羟基多巴胺 Caffeine,Parkinson Disease,Dose-effect relationship,6-OHDA
  • 相关文献

参考文献3

  • 1Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson's disease[J]. JAMA,2000,283(20) :2674-2679.
  • 2李玮,朱佩芳,周元国.腺苷A2a受体的矛盾作用:保护还是加重损伤?[J].生理科学进展,2006,37(3):225-228. 被引量:8
  • 3Chen JF,Xu K,Petzer JP,et al. Neuroprotection by caffeine and A(2A)adenosine receptor inactivation in a model of Parkinson's disease[J]. J Neurosci,2001,21(10) :143.

二级参考文献10

  • 1Fredholm BB,Arslan G,Halldner L,et al.Adenosine receptor signaling in vitro and in vivo.Drug Dev Res,2001,52:274~282.
  • 2Fredholm BB,Chen JF,Cunha RA,et al.Adenosine and brain function.Int Rev Neurobiol,2005,63:191~270.
  • 3Ohta A,Sitkovsky M.Role of G protein-coupled adenosine receptors in down-regulation of inflammation and protection from tissue damage.Nature,2001,414:916~920.
  • 4Xu K,Bastia E,Schwarzschild M.Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.Pharmacol Ther,2005,105:267~310.
  • 5Nishizaki T.ATP-and adenosine-mediated signaling in the central nervous system:adenosine stimulates glutamate release from astrocytes via A2a adenosine receptors.J Pharmacol Sci,2004,94:100~102.
  • 6Yu L,Huang Z,Mariani J,et al.Selective inactivation or reconstitution of adenosine A2a receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury.Nat Med,2004,10:1081~1087.
  • 7Blum D,Galas MC,Pintor A,et al.A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions:implications for the neuroprotective potential of A2A antagonists.J Neurosci,2003,23:5361~5369.
  • 8Tebano MT,Pintor A,Frank C,et al.Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre-and postsynaptic sites in the rat striatum.J Neurosci Res,2004,77:100~107.
  • 9Schiffmann SN,Dassesse D,d'Alcantara P,et al.A2A receptor and striatal cellular functions:regulation of gene expression,currents,and synaptic transmission.Neurology,2003,61:S24~29.
  • 10Rosin DL,Robeva A,Woodard RL,et al.Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system.J Comp Neurol,1998,401:163~186.

共引文献7

同被引文献20

  • 1陈新平,陈彪.吸烟、尼古丁与帕金森病的关系[J].中华神经科杂志,2005,38(6):400-402. 被引量:3
  • 2顾朱勤,陈彪.吸烟与帕金森病关系的研究进展[J].脑与神经疾病杂志,2006,14(1):78-79. 被引量:3
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:619
  • 4Zhang Z X, Roman G C, Hong Z, et al. Parkinson's dis- ease in China: prevalence in Beijing, Xian, and Shang- hai [ J ]. Lancet, 2005,365 ( 9459 ) :595-597.
  • 5Tan L C, Venketasubramanian N, Hong C Y, et al. Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians[J]. Neurology, 2004,62 ( 11 ) : 1999- 2004.
  • 6Porter B, Macfarlane R, Unwin N, et al. The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England [ J ]. Neuroepidemiology, 2006,26 (3) :156-161.
  • 7Elbaz A, Moisan F. Update in the epidemiology of Par- kinson's disease [ J ]. Curr Opin Neurol, 2008,21 (4) : 454 -460.
  • 8Thacker E L, O'Reilly E J, Weisskopf M G, et al. Tem- poral relationship between cigarette smoking and risk of Parkinson disease [ J]. Neurology, 2007,68 ( 10 ) : 764- 768.
  • 9Hancock D B, Martin E R, Stajich J M, et al. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in fam- ilies with Parkinson disease [ J ]. Arch Neurol, 2007,64 (4) :576-580.
  • 10Chen H, Huang X, Guo X, et al. Smoking duration, in- tensity, and risk of Parkinson disease [ J ]. Neurology, 2010,74 ( 11 ) :878-884.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部